NCT02915133

Brief Summary

Macular foveoschisis (MF) is a common complication of pathological myopia, which is characterized by choroid-retinal degeneration and vision impairment. Although pars plana vitrectomy (PPV) is the primary method for MF treatment, there is still a large proportion of recurrent MF due to the extremely long global axial length and posterior staphyloma. Macular buckling (MB) surgery aims at counteracting the traction exerted by the posterior staphyloma, and has been proven an effective method for treating MF. Optical Coherence Tomography (OCT) is widely used for the structural analysis of MF. Multifocol electroretinogram (mfERG) is an objective examination for visual evaluation. To our knowledge, there is a lack of data on the comprehensive visual function evaluations of MF patients associated with OCT findings. Our clinical trial aims to provide the structural and functional relationship in MF patients undergoing MB surgery, and find out potential factors to determine the visual prognosis.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2016

Completed
22 days until next milestone

First Posted

Study publicly available on registry

September 26, 2016

Completed
5 days until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 18, 2021

Completed
Last Updated

September 19, 2019

Status Verified

September 1, 2019

Enrollment Period

4.2 years

First QC Date

September 4, 2016

Last Update Submit

September 17, 2019

Conditions

Keywords

high myopiamyopia foveoschisismacular buckling

Outcome Measures

Primary Outcomes (2)

  • change from baseline OCT at 6 months

    6 month postoperatively

  • change from multifocal ERG at 6 months

    6 month postoperatively

Secondary Outcomes (1)

  • change from Best-corrected visual acuity (BCVA) at 6 months

    6 month postoperatively

Study Arms (1)

MF-MB

Consecutive participants with high myopic foveoschisis are scheduled to macular buckling (MB) surgery.

Procedure: macular buckling surgery

Interventions

Participants with high myopia foveoschisis are scheduled to macular buckling (MB) surgery.

MF-MB

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive participants with high myopia associated macular foveoschsis, who scheduled for surgery at Zhongshan Ophthalmic Center, Sun Yat-sen University.

You may qualify if:

  • axial length ≥ 26.5 mm or refractive error (spherical equivalent) ≥ 8.0 diopter;
  • macular foveoschisis that requires surgical intervention.

You may not qualify if:

  • ocular trauma or surgery history;
  • glaucoma, diabetic retinopathy;
  • intraocular active hemorrhage or inflammation;
  • unable to coordinate the OCT, mfERG, or other ophthalmological examinations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Ophthalmic Center, Sun Yat-sen University

Guangzhou, Guangdong, 510060, China

Location

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Fundus Disease Center of Zhongshan Ophthalmic Center

Study Record Dates

First Submitted

September 4, 2016

First Posted

September 26, 2016

Study Start

October 1, 2016

Primary Completion

December 1, 2020

Study Completion

September 18, 2021

Last Updated

September 19, 2019

Record last verified: 2019-09

Locations